glp-1 adoption Impact of Drug on Consumer Food Demand New Demand in an Old

Ma, Y., Ailawadi, K., Grewal, D

This is a trial starting dose, not an approved patient dose

Jeffrey Egler, said, The program virtually discards side effects for the majority of people, so more than 70% of individuals dont face any side effects

People could also potentially shift to a lower dose over time or switch from an injectable to a pill to make the drug more of a maintenance med to keep your weight stable

Reporting side effects Anyone who suspects they have experienced a side effect from a medicine or investigational product in the UK should report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

They affect 20%30% of patients and usually cease during long-term therapy after a few weeks